Ocular Assessments in Patients Treated With Tivdak® in Recurrent or Metastatic Cervical Cancer
Pfizer
Pfizer
University of Miami
Institut d'Investigació Biomèdica de Bellvitge
Louisiana State University Health Sciences Center in New Orleans
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Hospital Universitario de Fuenlabrada
Fujian Provincial Hospital
Kaohsiung Medical University Chung-Ho Memorial Hospital
Kaohsiung Medical University Chung-Ho Memorial Hospital
Region Stockholm
Haukeland University Hospital